Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
erythropoietin
- Development stage
- Approved
- Lead developer
- Amgen
- Modality
- Recombinant Proteins and Enzymes
- Administration
- Intravenous, Subcutaneous
01
Overview
Erythropoietin is a glycoprotein hormone primarily produced by the kidneys that regulates red blood cell production (erythropoiesis) in response to hypoxia. Recombinant forms, such as epoetin alfa, are used therapeutically to treat anemia associated with chronic kidney disease, chemotherapy for non-myeloid malignancies, HIV therapy (zidovudine-induced anemia), and to reduce the need for allogeneic blood transfusions during certain surgeries. Mechanistically, erythropoietin binds to the erythropoietin receptor (EPO-R) on erythroid progenitor cells in bone marrow, activating JAK2/STAT5 signaling pathways that promote survival and differentiation of these cells into mature red blood cells[1][4][5]. The drug is administered via intravenous or subcutaneous injection.
- Brand names
- EpogenProcritEprexNeoRecormonRetacrit
- Other names
- epoetin alfaepoetin betaepoetin zeta
02
Targets
Erythropoietin Receptor
Beyond the preview
Go deeper on erythropoietin.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on erythropoietin.